Editor’s Note: This interview was conducted at #Bio2018. Please pardon the background noise.
Jessica Rousset, Chief Operating Officer of CURE Pharmaceutical, discusses her company. CURE is an integrated drug delivery and development company and has proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilm). CURE is developing an array of products in cutting-edge delivery platforms and partners with biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel and Germany, among other markets.